Log In   |  Register Free Newsletter Subscription
Skip navigation
Zibb
Subscribe to Manufacturing Business Technology
FirstLight 
Email
Print
Reprints/License
RSS

E-pedigree enablement: Pfizer looks to SupplyScape for drug channel security

By Manufacturing Business Technology Staff -- Manufacturing Business Technology, 10/22/2007 2:44:00 PM

Pfizer, the world's largest pharmaceutical company, will use SupplyScape's E-Pedigree data management software to enhance patient safety, secure the drug supply channel, and meet regulatory compliance requirements.
 
E-Pedigree enables a secure chain of custody for a prescription drug by creating an electronic record or pedigree to trace each distribution of a given drug, from the first sale by the manufacturer through final sale to a pharmacy dispensing the drug. Built on open standards, E-Pedigree is one of the first electronic-pedigree products to receive GS1 EPCglobal Drug Pedigree Messaging Standard certification status. 

Pfizer's plan to implement E-Pedigree expands its channel security initiatives, which includes use of SupplyScape's product authentication solution, called RxAuthentication. 

"Pfizer is taking a leading role in attacking counterfeit and diversion threats to the drug supply chain to ensure patient safety," says Shabbir Dahod, founder and chairman of SupplyScape. "By implementing electronic pedigrees and product authentication to build a cohesive product security strategy, Pfizer is closing the gaps that exist today in the pharmaceutical distribution channel."

Email
Print
Reprints/License
RSS
Talkback
Reed Business Information Resource Center

Featured Company


Related Resources

Advertisement

Related Microsite Content

Related Links

Advertisement
Wonderware
NEWSLETTERS
Mid-Day Report
Innovation Strategies
Intelligent Manufacturing
Lean Enterprise



Please read our Privacy Policy

About Us   |   Advertising Info   |   Site Map   |   Contact Us   |   FREE Subscription   |   Affiliate Links   |   RSS
© 2009 Reed Business Information, a division of Reed Elsevier Inc. All rights reserved.
Use of this Web site is subject to its Terms of Use | Privacy Policy
Please visit these other Reed Business sites